C12N 5/0667
Adipose-derived stem cells [adsc]
Official title: {Adipose-derived stem cells [ADSC]; Adipose stromal stem cells}
C12N5/0667 (Adipose-derived stem cells [adsc]) appears on 452 US grants and 1,083 published applications in this corpus.
Search patents in C12N- Granted patents
- 452
- Published applications
- 1,083
- Assignees
- 520
- Inventors
- 1,776
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 1 |
| 2003 | 1 | 6 |
| 2004 | 1 | 9 |
| 2005 | 0 | 25 |
| 2006 | 2 | 11 |
| 2007 | 1 | 21 |
| 2008 | 3 | 16 |
| 2009 | 8 | 23 |
| 2010 | 5 | 35 |
| 2011 | 9 | 39 |
| 2012 | 14 | 50 |
| 2013 | 12 | 50 |
| 2014 | 22 | 59 |
| 2015 | 30 | 57 |
| 2016 | 35 | 63 |
| 2017 | 32 | 58 |
| 2018 | 29 | 58 |
| 2019 | 28 | 68 |
| 2020 | 33 | 70 |
| 2021 | 30 | 70 |
| 2022 | 31 | 74 |
| 2023 | 30 | 72 |
| 2024 | 31 | 52 |
| 2025 | 29 | 59 |
| 2026 | 34 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus therewith6 Oct 2026US 12,753,392 B2SymbioCellTech, LLC
- Method for manufacturing mitochondria-rich plasma22 Sep 2026US 12,741,068 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- Method for freezing cell structure25 Aug 2026US 12,714,096 B2Kyoto Prefectural Public University Corporation
- Activated mesenchymal stem cells for treating limb ischemia14 Jul 2026US 12,678,463 B2Cellin Technologies OÜ
- Membrane and method for culture and differentiation of cells7 Jul 2026US 12,674,128 B2Oujiang Laboratory
- Method for the production of bi-functional cells to treat neoplasia1 Oct 2026US 2026/0297162 A1Eir Biotherapies Srl
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Cgrp antagonist compositions and methods of use thereof10 Sep 2026US 2026/0263524 A1University of Miami
- Optimized cell transplant3 Sep 2026US 2026/0256844 A1Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Use of optimized cell transplant for treating diseases3 Sep 2026US 2026/0256845 A1Gwo Xi Stem Cell Applied Technology Co., Ltd.
Most cited
By later US patents
- Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration549US 6,200,606 B1DePuy Orthopaedics, Inc. · 2001
- Tissue-derived tissuegenic implants, and methods of fabricating and using same329US 8,883,210 B1Musculoskeletal Transplant Foundation · 2014
- Adipose-derived stem cells and lattices313US 6,777,231 B1The Regents of the University of California · 2004
- Method for processing and using adipose-derived stem cells142US 7,595,043 B2Cytori Therapeutics, Inc. · 2009
- Self-contained adipose derived stem cell processing unit140US 7,390,484 B2Cytori Therapeutics, Inc. · 2008